Trial intelligence / Profile preview

Phase IV comparison of human insulin versus insulin analog regimens in adults with type 1 diabetes

2006-005817-36Phase 4Active

Sponsor
Bellvitge University Hospital
Start
May 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of insulin aspart, insulin glargine, human insulin and insulin isophane in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Bellvitge University Hospital. Primary endpoints: HYPO score and Lability Index. Started May 2007; status: active.

02

Drugs

insulin aspartinsulin glarginehuman insulininsulin isophane
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2006-005817-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005817-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call